ABTHealthcare · Medical Devices
Abbott Laboratories
DeepValues Research covers Abbott Laboratories (ABT) with 9 research reports since May 26, 2026. The latest Deep Value Intelligence report (Sep 15, 2026) ends with a Neutral stance (3.05/5), with the stock at $103 against a headline intrinsic value of $59. Sector: Healthcare · Medical Devices. Neutral since Sep 1, 2026 (previously Bullish); 3 stance changes across 9 scored reports since May 26, 2026.
Stance history
Neutral since Sep 1, 2026 (previously Bullish); 3 stance changes across 9 scored reports since May 26, 2026.
Research timeline
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.05/5) on Abbott Laboratories (ABT), Sep 15, 2026. Price $103 vs intrinsic value $59. Abbott Laboratories is a high-quality healthcare and…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.05/5) on Abbott Laboratories (ABT), Sep 1, 2026. Price $110 vs intrinsic value $60. Abbott Laboratories (ABT) is a premium, wide-moat…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportBullish (3.05/5) on Abbott Laboratories (ABT), Aug 18, 2026. Price $110 vs intrinsic value $60. Abbott Laboratories (ABT) is a premier, durable…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportBullish (3.05/5) on Abbott Laboratories (ABT), Aug 4, 2026. Price $107 vs intrinsic value $60. Abbott Laboratories (ABT) is a high-quality, durable…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportBearish (3.05/5) on Abbott Laboratories (ABT), Jul 21, 2026. Price $102 vs intrinsic value $60. Abbott is a high-quality, diversified healthcare…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.15/5) on Abbott Laboratories (ABT), Jul 7, 2026. Price $96. Abbott is a high-quality healthcare franchise with durable positions in medical…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.15/5) on Abbott Laboratories (ABT), Jun 23, 2026. Price $88. Abbott is a high-quality healthcare franchise with clear scale advantages in…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.15/5) on Abbott Laboratories (ABT), Jun 9, 2026. Price $90. Abbott is a high-quality healthcare franchise with durable positions in medical…
-
Deep Value Intelligence
Abbott Laboratories (ABT) Deep Value Intelligence ReportNeutral (3.15/5) on Abbott Laboratories (ABT), May 26, 2026. Price $87. Abbott is a high-quality healthcare franchise with durable businesses in medical…
Compare with other Healthcare companies
All Healthcare stocks| Company | Latest stance | Reports |
|---|---|---|
| ABTAbbott Laboratories | Neutral3.05 | 9 |
| MDTMedtronic | Neutral3.33 | 2 |
| JNJJohnson & Johnson | Neutral3.08 | 3 |
| GRDN | Bearish3.16 | 1 |
| ALLOAllogene Therapeutics | Bearish3.10 | 1 |
| MRNA | Neutral3.01 | 1 |
| CRSPCRISPR Therapeutics | Neutral2.30 | 1 |
| INSMInsmed | Bearish2.52 | 1 |
| ABBVAbbVie | Bullish2.35 | 11 |










